Clinical Trial

Relationship Between FGF19 Overexpression and Disease Prognosis

Name: Relationship Between FGF19 Overexpression and Disease Prognosis — clinical trial record (NCT06938451)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FGF19

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A real-world study of FGF19 overexpression status and treatment outcome and prognosis in advanced hepatocellular carcinoma

Trial Details

NCT Number	NCT06938451
Lead Sponsor	Beijing Tsinghua Chang Gung Hospital
Conditions	Hepatocellular Carcinoma (HCC)
Enrollment	100 participants
Start Date	2025-05-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-22